| Year |
Citation |
Score |
| 2023 |
Taura J, López-Cano M, Fernández-Dueñas V, Ciruela F. Visualizing G Protein-Coupled Receptor-Receptor Interactions in Brain Using Proximity Ligation In Situ Assay. Current Protocols. 3: e794. PMID 37289022 DOI: 10.1002/cpz1.794 |
0.774 |
|
| 2022 |
Romero-Fernandez W, Taura JJ, Crans RAJ, Lopez-Cano M, Fores-Pons R, Narváez M, Carlsson J, Ciruela F, Fuxe K, Borroto-Escuela DO. The mGlu Receptor Protomer-Mediated Dopamine D Receptor Trans-Inhibition Is Dependent on the Adenosine A Receptor Protomer: Implications for Parkinson's Disease. Molecular Neurobiology. PMID 35829830 DOI: 10.1007/s12035-022-02946-9 |
0.767 |
|
| 2021 |
Hüll K, Fernández-Dueñas V, Schönberger M, López-Cano M, Trauner D, Ciruela F. Optical Control of Adenosine-Mediated Pain Modulation. Bioconjugate Chemistry. PMID 34448572 DOI: 10.1021/acs.bioconjchem.1c00387 |
0.548 |
|
| 2021 |
López-Cano M, Font J, Aso E, Sahlholm K, Cabré G, Giraldo J, De Koninck Y, Hernando J, Llebaria A, Fernández-Dueñas V, Ciruela F. Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects. British Journal of Pharmacology. PMID 34363210 DOI: 10.1111/bph.15645 |
0.67 |
|
| 2021 |
López-Cano M, Filgaira I, Nolen EG, Cabré G, Hernando J, Tosh DK, Jacobson KA, Soler C, Ciruela F. Optical control of adenosine A receptor function in psoriasis. Pharmacological Research. 105731. PMID 34157422 DOI: 10.1016/j.phrs.2021.105731 |
0.554 |
|
| 2020 |
Valle-León M, Callado LF, Aso E, Cajiao-Manrique MM, Sahlholm K, López-Cano M, Soler C, Altafaj X, Watanabe M, Ferré S, Fernández-Dueñas V, Menchón JM, Ciruela F. Decreased striatal adenosine A-dopamine D receptor heteromerization in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33010795 DOI: 10.1038/s41386-020-00872-9 |
0.736 |
|
| 2019 |
López-Cano M, Fernández-Dueñas V, Ciruela F. Proximity Ligation Assay Image Analysis Protocol: Addressing Receptor-Receptor Interactions. Methods in Molecular Biology (Clifton, N.J.). 2040: 41-50. PMID 31432474 DOI: 10.1007/978-1-4939-9686-5_3 |
0.472 |
|
| 2019 |
López-Cano M, Font J, Llebaria A, Fernández-Dueñas V, Ciruela F. Optical Modulation of Metabotropic Glutamate Receptor Type 5 In Vivo Using a Photoactive Drug. Methods in Molecular Biology (Clifton, N.J.). 1947: 351-359. PMID 30969427 DOI: 10.1007/978-1-4939-9121-1_20 |
0.539 |
|
| 2019 |
Aso E, Fernández-Dueñas V, López-Cano M, Taura J, Watanabe M, Ferrer I, Luján R, Ciruela F. Adenosine A-Cannabinoid CB Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ-Tetrahydrocannabinol-Induced Cognitive Impairment. Molecular Neurobiology. PMID 30610611 DOI: 10.1007/S12035-018-1456-3 |
0.787 |
|
| 2018 |
Núñez F, Taura J, Camacho J, López-Cano M, Fernández-Dueñas V, Castro N, Castro J, Ciruela F. PBF509, an Adenosine A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders. Frontiers in Pharmacology. 9: 1200. PMID 30405415 DOI: 10.3389/Fphar.2018.01200 |
0.797 |
|
| 2018 |
Taura J, Nolen EG, Cabré G, Hernando J, Squarcialupi L, López-Cano M, Jacobson KA, Fernández-Dueñas V, Ciruela F. Remote control of movement disorders using a photoactive adenosine A receptor antagonist. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29859955 DOI: 10.1016/J.Jconrel.2018.05.033 |
0.816 |
|
| 2018 |
Font J, López-Cano M, Notartomaso S, Scarselli P, Di Prieto P, Bresolí-Obach R, Battaglia G, Malhaire F, Rovira X, Catena J, Giraldo J, Pin JP, Fernández-Dueñas V, Goudet C, Nonell S, et al. Correction: Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator. Elife. 7. PMID 29313801 DOI: 10.7554/Elife.34752 |
0.515 |
|
| 2017 |
López-Cano M, Fernández-Dueñas V, Llebaria A, Ciruela F. Formalin Murine Model of Pain. Bio-Protocol. 7: e2628. PMID 34595296 DOI: 10.21769/BioProtoc.2628 |
0.416 |
|
| 2017 |
Massari CM, López-Cano M, Núñez F, Fernández-Dueñas V, Tasca CI, Ciruela F. Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder. Frontiers in Pharmacology. 8: 700. PMID 29046640 DOI: 10.3389/Fphar.2017.00700 |
0.528 |
|
| 2017 |
Moscoso-Castro M, López-Cano M, Gracia-Rubio I, Ciruela F, Valverde O. Cognitive impairments associated with alterations in synaptic proteins induced by the genetic loss of adenosine A2A receptors in mice. Neuropharmacology. PMID 28844595 DOI: 10.1016/J.Neuropharm.2017.08.027 |
0.519 |
|
| 2017 |
Morató X, Luján R, López-Cano M, Gandía J, Stagljar I, Watanabe M, Cunha RA, Fernández-Dueñas V, Ciruela F. The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo. Scientific Reports. 7: 9452. PMID 28842709 DOI: 10.1038/S41598-017-10147-X |
0.795 |
|
| 2017 |
Sahlholm K, Gómez-Soler M, Valle-León M, López-Cano M, Taura JJ, Ciruela F, Fernández-Dueñas V. Antipsychotic-Like Efficacy of Dopamine D2 Receptor-Biased Ligands is Dependent on Adenosine A2A Receptor Expression. Molecular Neurobiology. PMID 28779351 DOI: 10.1007/S12035-017-0696-Y |
0.723 |
|
| 2017 |
Morató X, López-Cano M, Canas PM, Cunha RA, Ciruela F. Brain Membrane Fractionation: An Ex Vivo Approach to Assess Subsynaptic Protein Localization. Journal of Visualized Experiments : Jove. PMID 28570537 DOI: 10.3791/55661 |
0.717 |
|
| 2017 |
Oliveira PA, Dalton JAR, López-Cano M, Ricarte A, Morató X, Matheus FC, Cunha AS, Müller CE, Takahashi RN, Fernández-Dueñas V, Giraldo J, Prediger RD, Ciruela F. Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia. Scientific Reports. 7: 1857. PMID 28500295 DOI: 10.1038/S41598-017-02037-Z |
0.814 |
|
| 2017 |
Font J, López-Cano M, Notartomaso S, Scarselli P, Di Pietro P, Bresolí-Obach R, Battaglia G, Malhaire F, Rovira X, Catena J, Giraldo J, Pin JP, Fernández-Dueñas V, Goudet C, Nonell S, et al. Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator. Elife. 6. PMID 28395733 DOI: 10.7554/Elife.23545 |
0.573 |
|
| 2016 |
Manils J, Eduard C, Viña-Vilaseca A, López-Cano M, Díez-Villanueva A, Gómez D, Marruecos L, Ferran M, Benito C, Perrino FW, Vavouri T, Maria de Anta J, Ciruela F, Soler C. The exonuclease TREX2 shapes psoriatic phenotype. The Journal of Investigative Dermatology. PMID 27365293 DOI: 10.1016/J.Jid.2016.05.122 |
0.432 |
|
| 2015 |
Fernández-Dueñas V, Taura JJ, Cottet M, Gómez-Soler M, López-Cano M, Ledent C, Watanabe M, Trinquet E, Pin JP, Luján R, Durroux T, Ciruela F. Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats. Disease Models & Mechanisms. 8: 57-63. PMID 25398851 DOI: 10.1242/Dmm.018143 |
0.737 |
|
| 2014 |
Fernández-Dueñas V, Gómez-Soler M, López-Cano M, Taura JJ, Ledent C, Watanabe M, Jacobson KA, Vilardaga JP, Ciruela F. Uncovering caffeine's adenosine A2A receptor inverse agonism in experimental parkinsonism. Acs Chemical Biology. 9: 2496-501. PMID 25268872 DOI: 10.1021/Cb5005383 |
0.76 |
|
| Show low-probability matches. |